Toxic tort litigation rarely stays static. Talc did not, and benzene may not either. What begins as workplace exposure litigation can migrate into the consumer market, bringing new defendants, new theories of liability, and a meaningfully different risk profile. The trajectory of talc litigation offers a useful framework for considering where benzene litigation could go next.
Both talc and benzene litigation started in familiar territory: allegations of occupational exposure, long latency periods, and claims heavily dependent on scientific evidence. The inflection point comes when that same narrative moves into everyday products.
Talc made that transition years ago, expanding from industrial-use allegations into claims involving baby powder, cosmetics, and other personal care products. That shift changed the litigation. The focus broadened to include more infrequent and lower-dose exposure allegations, as well as claims tied to marketing, disclosure, and consumer expectations—bringing more defendants and more varied legal theories into the mix.
Benzene litigation now shows some of the same early markers. Consumer suits involving benzoyl peroxide products have focused not only on personal injury, but also on whether consumers were misled about product safety, including allegations that benzoyl peroxide can break down into benzene under certain temperature and storage conditions. That distinction matters because it opens the door to consumer protection, warranty, and economic-loss theories that can scale differently from traditional toxic tort claims.
The comparison becomes especially important because economic-loss claims can lower barriers to filing, expand the potential claimant pool, and increase defense costs even before courts reach the underlying science. Talc followed that pattern. Benzene may be at an earlier stage, but the structure is familiar.
Talc did not become a systemic risk all at once. It expanded as exposure theories evolved, filings increased, and claims moved further into the consumer products sphere. KCIC’s most recent Asbestos Report reflects that talc claims remain a growing and closely watched area of litigation. Benzene filings do not appear to be as significant as talc today, but the early signals are notable.
The Judicial Panel on Multidistrict Litigation declined to centralize broader benzoyl peroxide litigation in 2024 and denied a defendant-specific bid in 2025. The result is a more fragmented litigation landscape, with coordination occurring through defendant-specific or jurisdiction-specific pathways rather than a single federal MDL. For defendants and insurers, that fragmentation can mean greater cost, less predictability, and more jurisdiction-specific pressure points.
For insurers, manufacturers, and corporate risk stakeholders, the key question is not whether benzene will replicate talc exactly. It is whether consumer-facing exposure theories will alter filing trends and defense strategy. Benzene litigation may still be in its early stages, but it is no longer only an occupational exposure story. Once a toxic tort theory reaches the consumer shelf, the litigation can change quickly.
Carrie Scott is KCIC’s technology lead, both in operations/infrastructure and for development. “I work with a talented group of people to make sure our technology stays innovative and top of the line to support our client’s needs,” she says. “I also focus on the Consulting side of our practice, leading many clients through their day-to-day and long-term strategic goals.”
Learn More About Carrie